基础医学与临床 ›› 2026, Vol. 46 ›› Issue (6): 845-849.doi: 10.16352/j.issn.1001-6325.2026.06.0845

• 研究论文 • 上一篇    下一篇

羧胺三唑抑制TNF-α诱导的类风湿关节炎患者来源的成纤维样滑膜细胞活化

李阳#, 卢珊#, 朱蕾*   

  1. 中国医学科学院北京协和医学院 基础医学研究所 药理学系,北京 100005
  • 收稿日期:2026-03-18 修回日期:2026-04-10 出版日期:2026-06-05 发布日期:2026-05-27
  • 通讯作者: *leizhu2004@126.com
  • 作者简介:#对本文有相同贡献
  • 基金资助:
    中国医学科学院医学与健康科技创新工程项目(2021-I2M-1-005,2025-I2M-KJ-009);中央高水平医院临床科研业务费(2022-PUMCH-C-025)

Carboxyamidotriazole inhibits TNF-α induced activation of fibroblast-like synovial cells from patients with rheumatoid arthritis

LI Yang#, LU Shan#, ZHU Lei*   

  1. Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China
  • Received:2026-03-18 Revised:2026-04-10 Online:2026-06-05 Published:2026-05-27
  • Contact: *leizhu2004@126.com

摘要: 目的 探究羧胺三唑(CAI)对TNF-α诱导的类风湿关节炎(RA)成纤维样滑膜细胞(FLS)活化的影响。方法 分离培养RA患者滑膜组织来源的FLS,经免疫荧光鉴定后,以TNF-α刺激,并加入不同浓度CAI处理。采用CCK-8法检测细胞增殖,ELISA法检测细胞上清中IL-6、IL-8和MMP-3含量,TransAM试剂盒检测核蛋白NF-κB p65的DNA结合活性。结果 TNF-α可显著促进RA-FLS增殖,上调IL-6、IL-8和MMP-3分泌,并增强NF-κB p65的DNA结合活性。10 μmol/L CAI可抑制TNF-α诱导的FLS增殖(P<0.05)、IL-6和MMP-3分泌(P<0.01)以及NF-κB p65活化(P<0.01),20、30和40 μmol/L CAI则可显著抑制TNF-α诱导的所有指标的升高(P<0.01)。结论 CAI可能通过抑制NF-κB活化而减少TNF-α诱导的RA-FLS增殖及IL-6、IL-8和MMP-3产生,提示CAI具有开发为RA治疗药物的潜力。

关键词: 羧胺三唑, 类风湿关节炎, 成纤维样滑膜细胞, TNF-α

Abstract: Objective To investigate the effect of carboxyamidotriazole (CAI) on TNF-α-induced activation of fibroblast-like synoviocyte(FLS) derived from patients with rheumatoid arthritis (RA). Methods FLS were isolated and cultured from synovial tissues of RA patients and identified by immunofluorescence. The cells were stimulated with TNF-α in the presence or absence of various concentrations of CAI. Cell proliferation was assessed by CCK-8 assay. The contents of IL-6, IL-8 and MMP-3 in the culture supernatant were measured by ELISA. NF-κB p65 DNA-binding activity in the nuclear extracts was detected using TransAM kit. Results TNF-α stimulation significantly promoted the proliferation of RA-FLS, upregulated the secretion of IL-6, IL-8 and MMP-3, and enhanced the DNA-binding activity of NF-κB p65. Treatment with 10 μmol/L CAI inhibited TNF-α-induced FLS proliferation (P<0.05), IL-6 and MMP-3 secretion (P<0.01), as well as NF-κB p65 activation (P<0.01). Furthermore, 20, 30 and 40 μmol/L CAI significantly suppressed all the TNF-α-induced elevations in the detected parameters (P<0.01). Conclusions CAI may attenuate TNF-α-induced proliferation and production of IL-6, IL-8 and MMP-3 in RA-FLS through suppressing NF-κB activation, suggesting that CAI has the potential to be developed as a therapeutic agent for RA.

Key words: carboxyamidotriazole, rheumatoid arthritis, fibroblast-like synoviocytes, TNF-α

中图分类号: